Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 27, 2025	Dec. 28, 2024
Cash flows from operating activities
Net income	$ 182,091	$ 163,939
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	35,825	30,796
Amortization of deferred financing fees	374	280
Equity-based compensation	15,406	14,184
Deferred taxes	22,197	(2,464)
(Gain) loss on disposal of property, plant, and equipment	(2,623)	128
Foreign currency transaction (gain) loss	(842)	1,436
Equity in net (income) loss of affiliates	(203)	1,466
Dividends from equity method investment	718	1,011
Change in fair value of contingent consideration	0	7,912
Change in assets and liabilities:
Accounts receivable	17,589	(3,858)
Floor plan receivables	(1,234)	(16,874)
Inventories	36,864	(18,902)
Other assets	(11,738)	8,045
Accounts payable	(17,103)	(4,762)
Accrued expenses and other liabilities	(26,156)	12,515
Net cash provided by operating activities	251,165	194,852
Cash flows from investing activities
Additions to property, plant, and equipment	(24,914)	(37,971)
Cash paid for equity method investment	(895)	0
Proceeds from floor plan loans	0	2,737
Acquisition, net of cash acquired	(24,636)	0
Proceeds from disposal of property, plant, and equipment	5,126	222
Net cash (used in) investing activities	(45,319)	(35,012)
Cash flows from financing activities
Changes in floor plan financing, net	(10,939)	(3,089)
Payments on long term debt	(1,012)	(20)
Payments of deferred financing fees	(1,014)	0
Payments for repurchase of common stock	(150,000)	(59,999)
Stock option exercises	3,836	285
Tax payments for equity-based compensation	(2,950)	(3,031)
Net cash (used in) financing activities	(162,079)	(65,854)
Effect of exchange rate changes on cash and cash equivalents	5,653	(7,296)
Net increase in cash and cash equivalents	49,420	86,690
Cash and cash equivalents at beginning of period	610,338	495,063
Cash and cash equivalents at end of period	$ 659,758	$ 581,753